ICM
CELG

IMS Capital Management’s Celgene Corp CELG Stock Holding History

IMS Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,969
Closed -$394K – 135
2019
Q3 		$394K Sell
3,969
-2,726
-41% -$259K 0.3% 96
2019
Q2 		$619K Hold
6,695
– – 0.46% 64
2019
Q1 		$632K Hold
6,695
– – 0.52% 63
2018
Q4 		$429K Sell
6,695
-310
-4% -$22.9K 0.4% 73
2018
Q3 		$627K Hold
7,005
– – 0.43% 61
2018
Q2 		$556K Sell
7,005
-15
-0.2% -$1.25K 0.35% 76
2018
Q1 		$733K Hold
7,020
– – 0.45% 64
2017
Q4 		$733K Buy
7,020
+380
+6% +$42.9K 0.45% 64
2017
Q3 		$968K Sell
6,640
-42
-0.6% -$5.72K 0.62% 43
2017
Q2 		$868K Buy
6,682
+247
+4% +$30.3K 0.82% 54
2017
Q1 		$801K Hold
6,435
– – 0.8% 53
2016
Q4 		$745K Buy
6,435
+1,800
+39% +$200K 0.8% 50
2016
Q3 		$484K Sell
4,635
-4,200
-48% -$455K 0.56% 59
2016
Q2 		$871K Hold
8,835
– – 1.02% 40
2016
Q1 		$884K Buy
+8,835
New +$910K 1.07% 32

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

IMS Capital Management's CELG Position: Q4 2019 in Review

IMS Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,969 shares — an estimated $394K sold.

IMS Capital Management first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $968K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • IMS Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • IMS Capital Management sold 3,969 Celgene Corp shares in Q4 2019, an estimated $394K.
  • IMS Capital Management first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • IMS Capital Management's Celgene Corp position peaked at $968K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on IMS Capital Management's 13F filing for Q4 2019, filed 15 Jan 2020.